Platform Technology Provides BIT Group with Competitive Edge

Share Article

Global contract manufacturer of complex medical instrumentation shares proprietary "Platform Technology" methods - proven product development techniques aimed at increasing speed-to-market while reducing cost.

BIT Analytical Instruments, Inc. has revealed "Platform Technology" as its verified speed-to-market advantage which is also aimed at reducing the tremendous costs associated with new product development of complex medical instrumentation.

As part of this approach, BIT Group draws from its more than 30 years of instrumentation projects to jumpstart new products with, not only specialized knowledge, but actual physical platform bases that have already successfully passed through the rigors of FDA audits. These fundamental building blocks can save significant time off the preliminary stages of prototyping and development, allowing the energy and focus to be placed on the heart of the product as well as the design of innovative, signature features.

Alfred Lang, CTO of BIT Analytical GmbH presented the highlights of Platform Technology to scientists and clinical product engineers at the 2008 AACC Annual Meeting in Washington DC. He explained that many instruments have common features such as mechanical drives, electronics/sensors and embedded software and interfaces. Such features can be brought to life through BIT Group's previously developed, tested and audited autonomous sub-modules, or ASM's. Use of ASM's have been proven to reduce time to market as well as development costs, decrease instrument production costs through economy of scale and guarantee product quality through proven technology.

For more than 30 years, BIT Group (http://www.bit-instruments.com) has provided instrument contract product development, manufacturing and after-sale services to medical, diagnostic, and bio-technology clients. As part of the financially-strong Messer Group, with representation in more than 100 countries, BIT Group offers its systems solutions worldwide and with adherence to ISO13485 and 9001 standards. As a FDA registered contract service provider, BIT Group meets the high standard of medical product regulation, meeting design-to-cost and time-to-market targets.

In June 2007, BIT Group expanded its operations in North America by acquiring interest in Source Scientific LLC, Irvine, CA ( http://www.sourcescientific.com ). The newly-combined BIT facilities function in clean, cell based manufacturing areas, based on the Kaizen philosophy of one piece work flow, ensuring superior production quality. An optical lab, wet test lab, design engineering centers and electronics testing lab are key areas where BIT Group provides innovation and superior quality for its customers. BIT Group provides single source from design and manufacturing to after-sale service with the highest quality standards according to ISO13485-2003 and ISO 9001-2000 and FDA registration, and is the base of the company's success.

BIT Group is the first OEM-Manufacturer of complex medical instrumentation that offers development, manufacturing and field service as well as complete FDA quality certification.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website